Key takeaways
- • Severity: Moderate — adjust timing or dose.
- • Rybelsus (type 2 diabetes (FDA-approved T2D, oral tablet)) and Warfarin (Coumadin) (Vitamin K antagonist (anticoagulant)).
- • Clinical management: Prescribers typically increase INR monitoring frequency during semaglutide initiation, dose titration, and any period of significant weight or dietary change. Defer all warfarin dose adjustments to the prescriber.
- • Monitoring: INR weekly during initiation and titration; more frequent INR checks during nausea, vomiting, or significant dietary changes.
Mechanism
Oral semaglutide can alter the absorption rate of co-administered drugs through delayed gastric emptying, and the SNAC absorption-enhancer formulation has been shown to affect warfarin pharmacokinetics modestly. More importantly, GLP-1-induced changes in diet, weight, and vitamin K intake during therapy can shift warfarin requirements and INR control.
Clinical management
Prescribers typically increase INR monitoring frequency during semaglutide initiation, dose titration, and any period of significant weight or dietary change. Defer all warfarin dose adjustments to the prescriber.
GLP1Zoom does not prescribe medications or recommend dose changes. Always confirm any adjustment with your prescribing clinician before changing how you take Rybelsus or Warfarin (Coumadin).
Monitoring
INR weekly during initiation and titration; more frequent INR checks during nausea, vomiting, or significant dietary changes.
When to call your doctor
- Unusual bruising or bleeding gums
- Blood in urine or stool, black tarry stools
- Severe headache or unexplained pain
In emergencies — severe abdominal pain, persistent vomiting, fainting, signs of severe hypoglycemia (confusion, seizures), or signs of bleeding — call 911 or go to the nearest emergency department.
Source / FDA label citation
Rybelsus USPI Section 7 (Drug Interactions) — warfarin and other coumarin derivatives recommended for INR monitoring.
Editorial confidence: 8/10. Lower scores reflect inferred mechanism rather than directly-labeled interaction. We re-verify against the active FDA prescribing information at least every 6 months.
Common questions
Can I take Warfarin (Coumadin) with Rybelsus?
Clinically meaningful — typically managed with dose/timing changes. Prescribers typically increase INR monitoring frequency during semaglutide initiation, dose titration, and any period of significant weight or dietary change. Defer all warfarin dose adjustments to the prescriber. Always confirm the specific plan with your prescriber — this page summarizes general pharmacology, not personal medical advice.
What's the mechanism of any Rybelsus + Warfarin (Coumadin) interaction?
Oral semaglutide can alter the absorption rate of co-administered drugs through delayed gastric emptying, and the SNAC absorption-enhancer formulation has been shown to affect warfarin pharmacokinetics modestly. More importantly, GLP-1-induced changes in diet, weight, and vitamin K intake during therapy can shift warfarin requirements and INR control.
What should I monitor when on Rybelsus + Warfarin (Coumadin)?
INR weekly during initiation and titration; more frequent INR checks during nausea, vomiting, or significant dietary changes.
When should I call my doctor?
Contact your prescriber if you notice any of: Unusual bruising or bleeding gums; Blood in urine or stool, black tarry stools; Severe headache or unexplained pain.
Related
This page summarizes general pharmacology from FDA-approved prescribing information. It is not a substitute for personalized medical advice. GLP1Zoom is an affiliate-only comparator — we do not prescribe or sell medications. Full disclaimer.